Suppr超能文献

HIV感染者的肝移植:仍然是一种实验性手术还是治疗标准?

Liver Transplantation in People Living with HIV: Still an Experimental Procedure or Standard of Care?

作者信息

Lynch Erica Nicola, Russo Francesco Paolo

机构信息

Department of Surgery, Oncology and Gastroenterology, Gastroenterology/Multivisceral Transplant Section, Padua University Hospital, 35128 Padua, Italy.

Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.

出版信息

Life (Basel). 2023 Sep 27;13(10):1975. doi: 10.3390/life13101975.

Abstract

Liver transplantation (LT) is the only curative treatment for various liver diseases, including acute liver failure, end-stage liver disease, and selected unresectable liver malignancies. Combination antiretroviral therapy has improved outcomes for people living with HIV (PLWH), transforming the status of acquired immune deficiency syndrome from a fatal disease to a chronic and manageable condition. These powerful antiviral therapies have not only increased the number of HIV+ enlisted patients by improving their survival but also made the use of HIV+ organs a viable option. In this review, we summarise current knowledge on the peculiarities of liver transplantation in PLWH. In particular, we focus on the indications, contraindications, specific considerations for treatment, and outcomes of LT in PLWH. Finally, we present available preliminary data on the use of HIV+ liver allografts.

摘要

肝移植(LT)是治疗各种肝脏疾病的唯一治愈性方法,包括急性肝衰竭、终末期肝病以及某些不可切除的肝脏恶性肿瘤。联合抗逆转录病毒疗法改善了艾滋病毒感染者(PLWH)的治疗效果,将获得性免疫缺陷综合征的状况从一种致命疾病转变为一种慢性且可控的疾病。这些强大的抗病毒疗法不仅通过提高艾滋病毒阳性入伍患者的生存率增加了其数量,还使使用艾滋病毒阳性器官成为一种可行的选择。在本综述中,我们总结了目前关于艾滋病毒感染者肝移植特殊性的知识。特别是,我们关注艾滋病毒感染者肝移植的适应症、禁忌症、治疗的特殊考虑因素以及预后。最后,我们展示了关于使用艾滋病毒阳性肝脏同种异体移植物的现有初步数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e07/10608432/ae4dc890e127/life-13-01975-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验